Pzena Investment Management LLC decreased its stake in Varex Imaging Co. (NASDAQ:VREX - Free Report) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,813,905 shares of the company's stock after selling 76,974 shares during the quarter. Pzena Investment Management LLC owned 9.25% of Varex Imaging worth $55,645,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently modified their holdings of the company. Quest Partners LLC acquired a new stake in shares of Varex Imaging during the third quarter worth about $41,000. US Bancorp DE raised its position in shares of Varex Imaging by 149.8% during the fourth quarter. US Bancorp DE now owns 7,386 shares of the company's stock worth $108,000 after purchasing an additional 4,429 shares during the period. New York State Common Retirement Fund raised its position in shares of Varex Imaging by 60.7% during the fourth quarter. New York State Common Retirement Fund now owns 9,531 shares of the company's stock worth $139,000 after purchasing an additional 3,600 shares during the period. Aigen Investment Management LP acquired a new stake in shares of Varex Imaging during the fourth quarter worth about $147,000. Finally, Inceptionr LLC acquired a new stake in shares of Varex Imaging during the fourth quarter worth about $168,000.
Varex Imaging Price Performance
NASDAQ VREX traded down $0.01 during midday trading on Friday, hitting $12.50. The company had a trading volume of 200,012 shares, compared to its average volume of 473,035. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02. Varex Imaging Co. has a twelve month low of $10.19 and a twelve month high of $18.30. The company has a market capitalization of $515 million, a PE ratio of -10.68 and a beta of 0.56. The firm has a 50-day moving average price of $13.42 and a 200-day moving average price of $13.39.
Varex Imaging (NASDAQ:VREX - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. As a group, analysts anticipate that Varex Imaging Co. will post 0.53 earnings per share for the current fiscal year.
Analyst Ratings Changes
VREX has been the topic of a number of recent research reports. Oppenheimer dropped their target price on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating on the stock in a research report on Friday, February 7th. StockNews.com raised Varex Imaging from a "hold" rating to a "buy" rating in a research report on Friday, February 7th. Finally, B. Riley reissued a "buy" rating and issued a $22.00 target price (up previously from $21.00) on shares of Varex Imaging in a research report on Friday, February 7th.
Check Out Our Latest Research Report on Varex Imaging
About Varex Imaging
(
Free Report)
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.
Featured Stories

Before you consider Varex Imaging, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Varex Imaging wasn't on the list.
While Varex Imaging currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.